Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Lexeo Therapeutics, Inc. market cap for the quarter ending 2026-08-10 was $379.87M, a 50.63% increase year-over-year.
Lexeo Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $365.99M, a 68.18% increase year-over-year.
Lexeo Therapeutics, Inc. market cap for the quarter ending 2026-05-07 was $456.21M, a 410.87% increase year-over-year.
Lexeo Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $424.52M, a 268.58% increase year-over-year.
Lexeo Therapeutics, Inc. market cap for fiscal 2026 was $379.87M.
Lexeo Therapeutics, Inc. market cap for fiscal 2025 was $724.17M, a 232.79% increase from fiscal 2024.
Lexeo Therapeutics, Inc. market cap for fiscal 2024 was $217.61M, a 39.15% decline from fiscal 2023.
Lexeo Therapeutics, Inc. market cap for fiscal 2023 was $357.59M.